hydroxyindoleacetic acid has been researched along with Brain Vascular Disorders in 17 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "For understanding of the role of monoamines in cerebral ischemia, 3-methoxy-4-hydroxyphenylglycol (MHPG), hydroxyindoleacetic acid (5HIAA) homovanillic acid (HVA) the three major monoamine metabolites in CSF of 33 patients and 18 controls were measured with high-performance liquid chromatography." | 3.68 | [The changes of monoamine metabolites in CSF of patients with cerebral stroke]. ( Tang, HZ, 1991) |
| "The concentrations of homovanillic acid (HVA), 3-methoxy, 4-hydroxyphenylglycol (MHPG), and 5-hydroxyindolylacetic acid (5-HIAA) were measured in samples of ventricular cerebrospinal fluid (CSF) taken from 15 patients who were comatose as a result of an acute head injury, a tumour, or a cerebrovascular accident." | 3.66 | Amine metabolites in ventricular cerebrospinal fluid in coma. ( Tsementzis, SA; Wilson, H; Yates, CM, 1979) |
| "It is proposed that the migraine attack is explicable by an interaction between the brain and the cranial circulation in subjects with unstable vascular and pain-control mechanisms." | 2.38 | The pathophysiology of migraine: a tentative synthesis. ( Lance, JW, 1992) |
| "Patients with hypoxic encephalopathy consisted of 5 with apallic syndrome and one patient with Lance-Adams syndrome." | 1.28 | [Study on the concentration of 5-hydroxyindoleacetic acid (5-HIAA) in the lumbar cerebrospinal fluid (CSF) in neurological diseases]. ( Fukuda, H; Hara, K; Kameyama, M; Nakamura, S; Udaka, F, 1989) |
| "Our results indicate that during cerebral ischemia a large increase in extracellular dopamine concentration in the caudate nucleus occurs, probably as a result of energy failure of the cell membranes." | 1.27 | Striatal dopamine in acute cerebral ischemia of stroke-resistant rats. ( Kawano, T; Miyake, H; Mori, K; Tsutsumi, K, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (76.47) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herbert, MK | 1 |
| Kuiperij, H | 1 |
| Bloem, BR | 1 |
| Verbeek, MM | 1 |
| Misra, SS | 1 |
| Singh, KS | 1 |
| Bhargava, KP | 1 |
| Jellinger, K | 1 |
| Riederer, P | 1 |
| Togashi, H | 1 |
| Matsumoto, M | 1 |
| Yoshioka, M | 1 |
| Hirokami, M | 1 |
| Minami, M | 1 |
| Saito, H | 1 |
| Mrsulja, BB | 1 |
| Mrsulja, BJ | 1 |
| Spatz, M | 1 |
| Klatzo, I | 1 |
| Yates, CM | 1 |
| Tsementzis, SA | 1 |
| Wilson, H | 1 |
| Lance, JW | 1 |
| Tang, HZ | 1 |
| Kawakami, M | 1 |
| Itoh, T | 1 |
| Minegishi, A | 1 |
| Ishizaki, T | 1 |
| Yoshida, Y | 1 |
| Ahagon, A | 1 |
| Shibata, N | 1 |
| Kobayashi, H | 1 |
| Lamers, KJ | 1 |
| Schoonderwaldt, HC | 1 |
| Borkent, MV | 1 |
| Theeuwes, AG | 1 |
| Doesburg, WH | 1 |
| Wevers, RA | 1 |
| Kawano, T | 1 |
| Tsutsumi, K | 1 |
| Miyake, H | 1 |
| Mori, K | 1 |
| Fukuda, H | 1 |
| Nakamura, S | 1 |
| Hara, K | 1 |
| Udaka, F | 1 |
| Kameyama, M | 1 |
| Himwich, WA | 1 |
| Fukuyama, GS | 1 |
| Johannsson, B | 1 |
| Roos, BE | 1 |
| Welch, KM | 1 |
| Meyer, JS | 1 |
| Kwant, S | 1 |
| Kawiak, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers[NCT01086696] | Early Phase 1 | 6 participants (Actual) | Interventional | 2010-03-09 | Terminated | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for hydroxyindoleacetic acid and Brain Vascular Disorders
| Article | Year |
|---|---|
The pathophysiology of migraine: a tentative synthesis.
Topics: Brain Stem; Calcitonin Gene-Related Peptide; Cerebrovascular Circulation; Cerebrovascular Disorders; | 1992 |
16 other studies available for hydroxyindoleacetic acid and Brain Vascular Disorders
| Article | Year |
|---|---|
Levels of HVA, 5-HIAA, and MHPG in the CSF of vascular parkinsonism compared to Parkinson's disease and controls.
Topics: Aged; Cerebrovascular Disorders; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; | 2013 |
Estimation of 5-hydroxytryptamine (5-HT) level in cerebrospinal fluid of patients with intracranial or spinal lesions.
Topics: Cerebrovascular Disorders; Chromatography, Paper; Humans; Hydroxyindoleacetic Acid; Paraplegia; Quad | 1967 |
[Central neurotransmitters in cerebral ischemia and stroke].
Topics: Animals; Blood-Brain Barrier; Brain Edema; Brain Ischemia; Cerebral Infarction; Cerebrovascular Diso | 1983 |
Neurochemical profiles in cerebrospinal fluid of stroke-prone spontaneously hypertensive rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Animals; Biogenic Monoamines; Blood Pressure; Cerebro | 1994 |
Brain serotonin after experimental vascular occlusion.
Topics: Animals; Cerebral Cortex; Cerebrovascular Disorders; Fenclonine; Gerbillinae; Hydroxyindoleacetic Ac | 1976 |
Amine metabolites in ventricular cerebrospinal fluid in coma.
Topics: Adolescent; Adult; Brain Injuries; Brain Neoplasms; Cerebrospinal Fluid Proteins; Cerebrovascular Di | 1979 |
[The changes of monoamine metabolites in CSF of patients with cerebral stroke].
Topics: Brain Ischemia; Cerebrovascular Disorders; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Ac | 1991 |
[Effects of idebenone on monoamine metabolites in the cerebrospinal fluid of patients with cerebrovascular dementia].
Topics: Aged; Benzoquinones; Biogenic Amines; Cerebrovascular Disorders; Chromatography, High Pressure Liqui | 1986 |
Plasma monoaminergic metabolites and catecholamines in subarachnoid hemorrhage. Clinical implications.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Catecholamines; Cerebrovascular Disorders; Dopamine; Ep | 1987 |
The effects of acute cerebrovascular disease on serum and cerebrospinal fluid parameters.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aspartate Aminotransferases; Cerebrospinal Fluid Prot | 1987 |
Striatal dopamine in acute cerebral ischemia of stroke-resistant rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Ischemia; Caudate Nucleus; Cerebrovascular Disorders; | 1988 |
[Study on the concentration of 5-hydroxyindoleacetic acid (5-HIAA) in the lumbar cerebrospinal fluid (CSF) in neurological diseases].
Topics: Adult; Aged; Alzheimer Disease; Brain Diseases; Cerebrovascular Disorders; Female; Humans; Hydroxyin | 1989 |
Genral neurophysiology (biochemical aspects).
Topics: Age Factors; Animals; Bipolar Disorder; Blood-Brain Barrier; Brain; Brain Diseases; Cerebrovascular | 1971 |
5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of patients with neurological diseases.
Topics: Adult; Brain Neoplasms; Central Nervous System Diseases; Cerebellar Ataxia; Cerebrovascular Disorder | 1974 |
Estimation of levels of serotonin and 5-hydroxyindoles in whole blood by an autoanalytical procedure: observations on the blood-brain barrier.
Topics: 5-Hydroxytryptophan; Aldehydes; Animals; Autoanalysis; Blood-Brain Barrier; Cerebrovascular Disorder | 1972 |
Investigations on urinary excretion of 5-hydroxyindoleacetic acid (5-HIAA) in patients after cerebral stroke.
Topics: Brain Diseases; Cerebral Hemorrhage; Cerebrovascular Disorders; Humans; Hydroxyindoleacetic Acid | 1968 |